Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BANF1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EIF1AD - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CST6 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CATSPER1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SART1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GAL3ST3 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
TSGA10IP - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
SF3B2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
GEO DataSets Gene Chromosome neighbors Homologene neighbors
DRAP1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
C11orf68 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
FOSL1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
CCDC85B - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
PACS1 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
KLC2 - Cyclin-dependent kinase inhibitor R547 effect on prostate cancer cell line: dose response and time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on